Abstract
A 60-year-old man underwent laparoscopic total proctocolectomy with ileostomy for advanced ulcerative colitis-associated rectal cancer. The final diagnosis was advanced cancer pT3, pN2 and M0 (pStage Ⅲb). Adjuvant therapy with XELOX was performed. However, abdominal CT revealed a liver metastasis and lymph node metastases in the pelvis 6 months after surgery. The patient was treated with FOLFIRI plus bevacizumab. After 20 courses of chemotherapy, the patient was considered to have experienced a clinical CR, which has been maintained for 3 years 5 months.
Publication types
-
Case Reports
-
English Abstract
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Bevacizumab / administration & dosage
-
Camptothecin / administration & dosage
-
Camptothecin / analogs & derivatives
-
Colitis, Ulcerative / complications*
-
Combined Modality Therapy
-
Fluorouracil / administration & dosage
-
Humans
-
Leucovorin / administration & dosage
-
Male
-
Middle Aged
-
Rectal Neoplasms / drug therapy*
-
Rectal Neoplasms / etiology
-
Rectal Neoplasms / pathology
-
Rectal Neoplasms / surgery
-
Recurrence
-
Remission Induction
Substances
-
Bevacizumab
-
Leucovorin
-
Fluorouracil
-
Camptothecin